Cytek Biosciences, Inc. (CTKB)
Nasdaq: CTKB · Laboratory Analytical Instruments · Fremont, CA · filing with the SEC since 2020
Grade5.8
◀ Past 7.4● Present 5.8▶ Future 4.1
Filings
151 filings since 2017 beside 314 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026Due nextAccelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.
Filings a yearinsider forms included
14794113806763
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Jul 15, 2026.A late-filing notice, Form NT 10-K, filed Mar 1, 2024.A late-filing notice, Form NT 10-Q, filed Nov 13, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 29, 2026
8-K items 5.03, 9.01
Charter, bylaw or fiscal-year change · Current report
Sep 23, 2026
Aug 24, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Aug 21, 2026
40 of 151 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.